Recent News

• 06.12.2025 - Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
• 06.12.2025 - Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
• 06.12.2025 - Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
• 05.14.2025 - Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
• 05.14.2025 - Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
• 05.14.2025 - Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
• 05.14.2025 - Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting
• 05.14.2025 - Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting
• 05.14.2025 - Bank of America Global Healthcare Conference
• 05.14.2025 - Bank of America Global Healthcare Conference

Recent Filings

• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 8-K Current report
• 06.02.2025 - 144 Report of proposed sale of securities